Barriers to care in chronic disease: How to bridge the treatment gap

Consultant

Volumn 46, Issue 10, 2006, Pages 1149-1152

  Shahady, Edward J ^a,b,c  

^a UNIVERSITY OF MIAMI   (United States)

^b Tallahassee Memorial Hospital Family Practice Residency Program   (United States)

^c Florida Academy of Family Physicians Foundation   (United States)

Author keywords

Adherence; Barriers to care; Chronic disease

Indexed keywords

CHRONIC DISEASE; FOLLOW UP; HUMAN; LONG TERM CARE; MEDICAL PRACTICE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; TRADITIONAL MEDICINE; TREATMENT OUTCOME;

EID: 33749319939     PISSN: 00107069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Shahady EJ. Letter to the editor on performance gap. JAMA. 2001;286:1834.
2. Institute of Medicine Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
3. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.
4. Anderson RM, Funnell MM. Compliance and adherence are dysfunctional concepts in diabetes care. Diabetes Educ. 2000;26:597-604.
5. Gilbert JR, Evans CE, Haynes RB, Tugwell P. Predicting compliance with a regimen of digoxin therapy in family practice. Can Med Assoc J. 1980;123:119-122.
6. Schillinger D, Piette J, Grumbach K, et al. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med. 2003;163:83-90.
7. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse. Do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164:1749-1755.
8. Donovan JL, Blake DR Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med. 1992;34:507-513.
9. Ockene IS, Hayman LL, Pasternak RC, et al. Task force #4-adherence issues and behavior changes: achieving a long-term solution. 33rd Bethesda Conference. J Am Coll Cardiol. 2002;40:630-640.
10. Ellis JJ, Erickson SR, Stevenson JG, et al. Sub-optimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med. 2004;19:638-645.
11. Graziani C, Rosenthal MP, Diamond JJ. Diabetes education program use and patient-perceived barriers to attendance. Fam Med. 1999;31:358-363.
12. Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
13. Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47:345-351.
14. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135:825-834.
15. Grant RW, Cagliero E, Dubey AK, et al. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabet Med. 2004;21:150-155.
16. Grant RW, Buse JB, Meigs JB. Quality of diabetes care in US academic medical centers: low rates of medical regimen change. Diabetes Care. 2005;28:337-442.